CN103816223A - 无糖型川芎茶调颗粒 - Google Patents
无糖型川芎茶调颗粒 Download PDFInfo
- Publication number
- CN103816223A CN103816223A CN201410062343.0A CN201410062343A CN103816223A CN 103816223 A CN103816223 A CN 103816223A CN 201410062343 A CN201410062343 A CN 201410062343A CN 103816223 A CN103816223 A CN 103816223A
- Authority
- CN
- China
- Prior art keywords
- preparation
- chuan xiong
- xiong tea
- granular preparation
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008187 granular material Substances 0.000 title claims abstract description 58
- 241000112528 Ligusticum striatum Species 0.000 title abstract 6
- 238000002360 preparation method Methods 0.000 claims abstract description 231
- 239000000463 material Substances 0.000 claims abstract description 45
- 206010063659 Aversion Diseases 0.000 claims abstract description 6
- 206010019233 Headaches Diseases 0.000 claims abstract description 6
- 231100000869 headache Toxicity 0.000 claims abstract description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 180
- 238000000034 method Methods 0.000 claims description 91
- 239000000284 extract Substances 0.000 claims description 60
- 239000002671 adjuvant Substances 0.000 claims description 38
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 37
- 239000000341 volatile oil Substances 0.000 claims description 34
- 239000007788 liquid Substances 0.000 claims description 33
- 239000000203 mixture Substances 0.000 claims description 29
- 239000003814 drug Substances 0.000 claims description 26
- 239000000843 powder Substances 0.000 claims description 25
- 239000004375 Dextrin Substances 0.000 claims description 23
- 229920001353 Dextrin Polymers 0.000 claims description 23
- 241000244365 Ligusticum sinense Species 0.000 claims description 23
- 235000019425 dextrin Nutrition 0.000 claims description 23
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 22
- 239000006286 aqueous extract Substances 0.000 claims description 21
- 239000008101 lactose Substances 0.000 claims description 19
- 229930006000 Sucrose Natural products 0.000 claims description 17
- 239000005720 sucrose Substances 0.000 claims description 17
- 238000003809 water extraction Methods 0.000 claims description 16
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 15
- 239000012528 membrane Substances 0.000 claims description 14
- 239000012467 final product Substances 0.000 claims description 11
- 235000021050 feed intake Nutrition 0.000 claims description 10
- 239000012567 medical material Substances 0.000 claims description 10
- 238000004821 distillation Methods 0.000 claims description 9
- 239000002131 composite material Substances 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 7
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 6
- 206010028748 Nasal obstruction Diseases 0.000 claims description 5
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 3
- 229920000881 Modified starch Polymers 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 3
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 3
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 3
- 239000013618 particulate matter Substances 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 241000213006 Angelica dahurica Species 0.000 abstract description 3
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract description 3
- 241000758794 Asarum Species 0.000 abstract 1
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 1
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 1
- 240000009215 Nepeta cataria Species 0.000 abstract 1
- 235000010679 Nepeta cataria Nutrition 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 206010037660 Pyrexia Diseases 0.000 abstract 1
- ZDKZHVNKFOXMND-UHFFFAOYSA-N epinepetalactone Chemical compound O=C1OC=C(C)C2C1C(C)CC2 ZDKZHVNKFOXMND-UHFFFAOYSA-N 0.000 abstract 1
- 229940010454 licorice Drugs 0.000 abstract 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 93
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 93
- 229940114124 ferulic acid Drugs 0.000 description 93
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 93
- 235000001785 ferulic acid Nutrition 0.000 description 93
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 93
- 239000000243 solution Substances 0.000 description 47
- 238000012360 testing method Methods 0.000 description 27
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 25
- 239000000047 product Substances 0.000 description 25
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 24
- 239000000706 filtrate Substances 0.000 description 13
- 239000013558 reference substance Substances 0.000 description 12
- 239000000126 substance Substances 0.000 description 12
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- 238000011835 investigation Methods 0.000 description 8
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 6
- 239000000853 adhesive Substances 0.000 description 6
- 230000001070 adhesive effect Effects 0.000 description 6
- 239000001768 carboxy methyl cellulose Substances 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 6
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 239000007921 spray Substances 0.000 description 6
- 238000004809 thin layer chromatography Methods 0.000 description 6
- 239000002775 capsule Substances 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 239000000741 silica gel Substances 0.000 description 5
- 229910002027 silica gel Inorganic materials 0.000 description 5
- 229960000583 acetic acid Drugs 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 239000012362 glacial acetic acid Substances 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 239000006187 pill Substances 0.000 description 4
- 238000005507 spraying Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 241000125183 Crithmum maritimum Species 0.000 description 3
- 244000303040 Glycyrrhiza glabra Species 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 235000019410 glycyrrhizin Nutrition 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 238000001728 nano-filtration Methods 0.000 description 3
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 239000007901 soft capsule Substances 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 241001289295 Asarum sieboldii Species 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- 241001278898 Glycyrrhiza inflata Species 0.000 description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N ethyl acetate Substances CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 235000011477 liquorice Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 125000000185 sucrose group Chemical group 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- DGFLRNOCLJGHLY-ZDUSSCGKSA-N 5-O-Methylvisamminol Chemical compound O1C(C)=CC(=O)C2=C1C=C1O[C@H](C(C)(C)O)CC1=C2OC DGFLRNOCLJGHLY-ZDUSSCGKSA-N 0.000 description 1
- DGFLRNOCLJGHLY-CYBMUJFWSA-N 5-O-methylvisamminol Natural products O(C)c1c2C(=O)C=C(C)Oc2cc2O[C@@H](C(O)(C)C)Cc12 DGFLRNOCLJGHLY-CYBMUJFWSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- 241000758795 Aristolochiaceae Species 0.000 description 1
- 241001472196 Asarum heterotropoides Species 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 241000382951 Hansenia forbesii Species 0.000 description 1
- 241000533388 Hansenia weberbaueriana Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 235000001878 Mentha haplocalyx Nutrition 0.000 description 1
- 244000280293 Mentha haplocalyx Species 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 241001180873 Saposhnikovia divaricata Species 0.000 description 1
- 241000951376 Schizonepeta tenuifolia Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010041591 Spinal osteoarthritis Diseases 0.000 description 1
- XUJMHSCMPCZWOV-LAQQPNPASA-N [(1S,1'S,3'R,4R,4'R,5R,5'R,6'R,10'S,12'S,16'R,18'S,21'R)-2-hydroxy-1,4',6',12',17',17'-hexamethyl-18'-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyspiro[3,6-dioxabicyclo[3.1.0]hexane-4,8'-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docos-13-ene]-3'-yl] acetate Chemical compound C[C@@H]1C[C@]2(OC(O)[C@@]3(C)O[C@@H]23)O[C@H]2C[C@@]3(C)C4=CC[C@@H]5[C@]6(C[C@@]46C[C@@H](OC(C)=O)[C@]3(C)[C@@H]12)CC[C@H](O[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O)C5(C)C XUJMHSCMPCZWOV-LAQQPNPASA-N 0.000 description 1
- PQLVXDKIJBQVDF-UHFFFAOYSA-N acetic acid;hydrate Chemical compound O.CC(O)=O PQLVXDKIJBQVDF-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 208000036319 cervical spondylosis Diseases 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- XUJMHSCMPCZWOV-UHFFFAOYSA-N cimicifugoside Natural products C1C23CC(OC(C)=O)C4(C)C5C(C)CC6(C7OC7(C)C(O)O6)OC5CC4(C)C2=CCC(C2(C)C)C31CCC2OC1OCC(O)C(O)C1O XUJMHSCMPCZWOV-UHFFFAOYSA-N 0.000 description 1
- BTPYUWOBZFGKAI-UHFFFAOYSA-N cimiracemoside C Natural products C1C23CCC4(C)C5C(C)CC(C(O6)C(C)(C)O)OC56C(O)C4(C)C2CCC(C2(C)C)C31CCC2OC1OCC(O)C(O)C1O BTPYUWOBZFGKAI-UHFFFAOYSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000000385 dialysis solution Substances 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- WGLUMOCWFMKWIL-UHFFFAOYSA-N dichloromethane;methanol Chemical compound OC.ClCCl WGLUMOCWFMKWIL-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000013583 drug formulation Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- OAMZXMDZZWGPMH-UHFFFAOYSA-N ethyl acetate;toluene Chemical compound CCOC(C)=O.CC1=CC=CC=C1 OAMZXMDZZWGPMH-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000011034 membrane dialysis Methods 0.000 description 1
- -1 micropill Substances 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N p-menthan-3-ol Chemical compound CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 208000005801 spondylosis Diseases 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
枸橼酸量 | 0 | 0.1 | 0.25 | 0.5 | 0.75 | 1.5 | 2 | 2.5 | 3 | 5 | 10 |
样品编号 | D101 | D102 | D103 | D104 | D105 | D106 | D107 | D108 | D109 | D110 | D111 |
枸橼酸量 | 0 | 0.1 | 0.25 | 0.5 | 0.75 | 1.5 | 2 | 2.5 | 3 | 5 | 10 |
样品编号 | D201 | D202 | D203 | D204 | D205 | D206 | D207 | D208 | D209 | D210 | D211 |
枸橼酸量 | 0 | 0.1 | 0.25 | 0.5 | 0.75 | 1.5 | 2 | 2.5 | 3 | 5 | 10 |
样品编号 | D301 | D302 | D303 | D304 | D305 | D306 | D307 | D308 | D309 | D310 | D311 |
Claims (18)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410062343.0A CN103816223B (zh) | 2014-02-24 | 2014-02-24 | 无糖型川芎茶调颗粒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410062343.0A CN103816223B (zh) | 2014-02-24 | 2014-02-24 | 无糖型川芎茶调颗粒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103816223A true CN103816223A (zh) | 2014-05-28 |
CN103816223B CN103816223B (zh) | 2017-08-25 |
Family
ID=50751704
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410062343.0A Active CN103816223B (zh) | 2014-02-24 | 2014-02-24 | 无糖型川芎茶调颗粒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103816223B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108404140A (zh) * | 2016-06-01 | 2018-08-17 | 湖南安邦制药有限公司 | 一种挥发油的包合工艺 |
CN113552276A (zh) * | 2021-07-06 | 2021-10-26 | 贵州健兴药业有限公司 | 一种川芎茶调滴丸的检测方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1739612A (zh) * | 2005-09-08 | 2006-03-01 | 王衡新 | 疏风止痛的中药制剂及其制备方法和质量控制方法 |
CN101313936A (zh) * | 2007-06-01 | 2008-12-03 | 北京亚东生物制药有限公司 | 一种疏风止痛的药物组合物及制备方法和质量控制方法 |
CN101829191A (zh) * | 2009-09-22 | 2010-09-15 | 贵州健兴药业有限公司 | 一种治疗头痛的川芎茶调滴丸及其制备方法 |
CN102579576A (zh) * | 2012-02-27 | 2012-07-18 | 贵州威门药业股份有限公司 | 川芎茶调颗粒提取物及其制剂制备方法 |
CN102885889A (zh) * | 2012-11-05 | 2013-01-23 | 太极集团重庆中药二厂有限公司 | 川芎茶调丸的制备方法 |
-
2014
- 2014-02-24 CN CN201410062343.0A patent/CN103816223B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1739612A (zh) * | 2005-09-08 | 2006-03-01 | 王衡新 | 疏风止痛的中药制剂及其制备方法和质量控制方法 |
CN101313936A (zh) * | 2007-06-01 | 2008-12-03 | 北京亚东生物制药有限公司 | 一种疏风止痛的药物组合物及制备方法和质量控制方法 |
CN101829191A (zh) * | 2009-09-22 | 2010-09-15 | 贵州健兴药业有限公司 | 一种治疗头痛的川芎茶调滴丸及其制备方法 |
CN102579576A (zh) * | 2012-02-27 | 2012-07-18 | 贵州威门药业股份有限公司 | 川芎茶调颗粒提取物及其制剂制备方法 |
CN102885889A (zh) * | 2012-11-05 | 2013-01-23 | 太极集团重庆中药二厂有限公司 | 川芎茶调丸的制备方法 |
Non-Patent Citations (3)
Title |
---|
国家药典委员会: "《中华人民共和国药典2010年版第二增补本》", 30 September 2013 * |
张丽艳等: ""膜分离技术应用于川芎茶调颗粒提取工艺研究"", 《中国中药杂志》 * |
罗明生等: "《中国药用辅料》", 30 April 2006 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108404140A (zh) * | 2016-06-01 | 2018-08-17 | 湖南安邦制药有限公司 | 一种挥发油的包合工艺 |
CN113552276A (zh) * | 2021-07-06 | 2021-10-26 | 贵州健兴药业有限公司 | 一种川芎茶调滴丸的检测方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103816223B (zh) | 2017-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102657823B (zh) | 一种具有抗癌作用的中药组合物及其制备方法和检测方法 | |
CN101564514B (zh) | 一种小儿风热清颗粒的分析方法 | |
CN101422563B (zh) | 治疗小儿咽喉炎的中药组合物及其制备方法和质量检测方法 | |
CN103800438A (zh) | 川芎茶调制剂和制法 | |
CN103784505A (zh) | 川芎茶调制剂 | |
CN102091168A (zh) | 一种中药制剂血府逐瘀胶囊的质量控制方法 | |
CN103412059B (zh) | 一种妇炎康分散片质量控制方法 | |
CN102579734B (zh) | 骨愈灵中药组合物及其制备方法和检测方法 | |
CN100482262C (zh) | 治疗免疫疾病的草药药物组合物 | |
CN106620610A (zh) | 一种甘草泻心颗粒的制备方法 | |
CN101690757B (zh) | 一种牛黄上清制剂的制备方法 | |
CN101569712A (zh) | 一种治疗感冒风寒的中药组合物 | |
CN101716270B (zh) | 一种调经活血中药复方制剂的检测方法 | |
CN103816223A (zh) | 无糖型川芎茶调颗粒 | |
CN104950068B (zh) | 补肾祛风更年合剂的质量检测方法 | |
CN101732527B (zh) | 舒肝颗粒的检测方法 | |
CN101057895B (zh) | 治疗妇科疾病的妇炎舒制剂及其质量检测方法 | |
CN102688336A (zh) | 一种牛黄上清组合物及其制备方法 | |
CN102590423B (zh) | 川芎茶调颗粒制剂指纹图谱的测定方法 | |
CN101647997B (zh) | 感冒疏风胶囊及其制备方法和质量控制方法 | |
CN100515476C (zh) | 复方金蒲胶囊及其制备方法、质量控制方法 | |
CN101385834B (zh) | 一种治疗泌尿***疾病的药物组合物及其制备方法 | |
CN1935240A (zh) | 一种治疗小儿感冒的中药组合物制剂的质量控制方法 | |
CN103083458A (zh) | 温清饮复方配方颗粒及其制备方法和检测方法 | |
CN101869644A (zh) | 乌鸡白凤分散片及其制备工艺 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Sugar free Chuanxiong chatiao granules Effective date of registration: 20210113 Granted publication date: 20170825 Pledgee: Bank of Communications Co.,Ltd. Guizhou Branch Pledgor: GUIZHOU WARMEN PHARMACEUTICAL Co.,Ltd. Registration number: Y2021520000001 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210723 Granted publication date: 20170825 Pledgee: Bank of Communications Co.,Ltd. Guizhou Branch Pledgor: GUIZHOU WARMEN PHARMACEUTICAL Co.,Ltd. Registration number: Y2021520000001 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Sugar free Chuanxiong chatiao granule Effective date of registration: 20210819 Granted publication date: 20170825 Pledgee: Bank of Communications Co.,Ltd. Guizhou Branch Pledgor: GUIZHOU WARMEN PHARMACEUTICAL Co.,Ltd. Registration number: Y2021520000011 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220601 Granted publication date: 20170825 Pledgee: Bank of Communications Co.,Ltd. Guizhou Branch Pledgor: GUIZHOU WARMEN PHARMACEUTICAL Co.,Ltd. Registration number: Y2021520000011 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Sugar free Chuanxiong chatiao granules Effective date of registration: 20220719 Granted publication date: 20170825 Pledgee: Bank of Communications Co.,Ltd. Guizhou Branch Pledgor: GUIZHOU WARMEN PHARMACEUTICAL Co.,Ltd. Registration number: Y2022520000033 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230523 Granted publication date: 20170825 Pledgee: Bank of Communications Co.,Ltd. Guizhou Branch Pledgor: GUIZHOU WARMEN PHARMACEUTICAL Co.,Ltd. Registration number: Y2022520000033 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Sugar-free Chuanxiong Chadiao Granules Effective date of registration: 20230530 Granted publication date: 20170825 Pledgee: Bank of Communications Co.,Ltd. Guizhou Branch Pledgor: GUIZHOU WARMEN PHARMACEUTICAL Co.,Ltd. Registration number: Y2023520000021 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20170825 Pledgee: Bank of Communications Co.,Ltd. Guizhou Branch Pledgor: GUIZHOU WARMEN PHARMACEUTICAL Co.,Ltd. Registration number: Y2023520000021 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Sugar free Chuanxiong Tea Tiao Granules Granted publication date: 20170825 Pledgee: Bank of Communications Co.,Ltd. Guizhou Branch Pledgor: GUIZHOU WARMEN PHARMACEUTICAL Co.,Ltd. Registration number: Y2024520000019 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |